Estimated number of prevalent cases of metastatic bone disease in the US adult population.

Clinical Epidemiology
Shuling LiThomas J Arneson

Abstract

The prevalence of metastatic bone disease in the US population is not well understood. We sought to estimate the current number of US adults with metastatic bone disease using two large administrative data sets. Prevalence was estimated from a commercially insured cohort (ages 18-64 years, MarketScan database) and from a fee-for-service Medicare cohort (ages ≥65 years, Medicare 5% database) with coverage on December 31, 2008, representing approximately two-thirds of the US population in each age group. We searched for claims-based evidence of metastatic bone disease from January 1, 2004, using a combination of relevant diagnosis and treatment codes. The number of cases in the US adult population was extrapolated from age- and sex-specific prevalence estimated in these cohorts. Results are presented for all cancers combined and separately for primary breast, prostate, and lung cancer. In the commercially insured cohort (mean age = 42.3 years [SD = 13.1]), we identified 9505 patients (0.052%) with metastatic bone disease. Breast cancer was the most common primary tumor type (n = 4041). In the Medicare cohort (mean age = 75.6 years [SD = 7.8]), we identified 6427 (0.495%) patients with metastatic bone disease. Breast (n = 1798) an...Continue Reading

References

Apr 16, 2004·The New England Journal of Medicine·G David Roodman
Oct 2, 2004·The Oncologist·Robert E Coleman
Feb 19, 2005·Current Treatment Options in Oncology·Allan Lipton
Jun 28, 2005·Critical Reviews in Oncology/hematology·Giovanni Selvaggi, Giorgio V Scagliotti
Oct 26, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robert E Coleman
Apr 24, 2007·Cancer·Kathy L Schulman, Joseph Kohles

❮ Previous
Next ❯

Citations

Jan 7, 2014·Cancer Metastasis Reviews·Daniel F Camacho, Kenneth J Pienta
Nov 21, 2014·Head and Neck Pathology·Abraham HirshbergIlana Kaplan
Nov 26, 2013·The Orthopedic Clinics of North America·Felix H Cheung
Sep 28, 2015·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Mark D DaneseDeepa Lalla
Mar 27, 2015·Advances in Orthopedics·Daniel A Müller, Rodolfo Capanna
Jun 1, 2015·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Peter HoskinBranislav Jeremic
Apr 17, 2016·Breast Cancer Research and Treatment·Alexander LiedeSteven A Narod
Apr 22, 2015·Annals of Epidemiology·Elizabeth T JensenEvan S Dellon
Jan 18, 2015·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Jorge ArellanoYi Qian
May 10, 2016·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Srinivas RamanMichael Brundage
Aug 27, 2016·International Journal of Molecular Sciences·Vassilis KoulouliasJohn R Kouvaris
Oct 18, 2016·Lancet·Chris MaherRachelle Buchbinder
Aug 13, 2014·World Journal of Clinical Oncology·Nadia RucciAdriano Angelucci
Dec 17, 2019·Acta ortopedica brasileira·Lucas SantiagoAna Valéria Brunetti Rigolino
Dec 9, 2016·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Catherine H Van PoznakJoseph M Unger
Mar 13, 2020·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Timothy A Damron, Kenneth A Mann
Jun 6, 2018·Topics in Magnetic Resonance Imaging : TMRI·Kamran AhrarJason R Stafford
Aug 5, 2020·Molecular Biology Reports·Filippo MiglioriniArne Driessen
Jan 4, 2019·Journal of Biological Engineering·Shantanu PradhanJohn H Slater
Jul 8, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Michael MeisenheimerElisabeth Eppard
May 16, 2020·Der Radiologe·Felix WuennemannChristoph Rehnitz
Jun 15, 2021·Frontiers in Oncology·Felix EhretAlexander Muacevic
Jul 6, 2021·Frontiers in Oncology·Ahmet S TuncerogluSalma K Jabbour
Oct 14, 2021·European Journal of Orthopaedic Surgery & Traumatology : Orthopédie Traumatologie·Shinji TsukamotoAndreas F Mavrogenis

❮ Previous
Next ❯

Software Mentioned

SAS
MarketScan

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.